Question
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industryJohnson and Johnson (J&J) and Pfizer, Inc. ($
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industryJohnson and Johnson (J&J) and Pfizer, Inc. ($ in millions, except per share amounts).
Balance Sheets ($ in millions, except per share data) | |||||||
J&J | Pfizer | ||||||
Assets: | |||||||
Cash | $ | 10,641 | $ | 5,801 | |||
Short-term investments | 5,037 | 11,293 | |||||
Accounts receivable (net) | 7,589 | 9,790 | |||||
Inventories | 4,520 | 7,459 | |||||
Other current assets | 4,395 | 4,260 | |||||
Current assets | 32,182 | 38,603 | |||||
Property, plant, and equipment (net) | 12,338 | 20,779 | |||||
Intangibles and other assets | 17,214 | 70,539 | |||||
Total assets | $ | 61,734 | $ | 129,921 | |||
Liabilities and Shareholders' Equity: | |||||||
Accounts payable | $ | 5,911 | $ | 3,546 | |||
Short-term notes | 2,756 | 10,435 | |||||
Other current liabilities | 8,218 | 13,113 | |||||
Current liabilities | 16,885 | 27,094 | |||||
Long-term debt | 3,830 | 6,630 | |||||
Other long-term liabilities | 5,852 | 22,847 | |||||
Total liabilities | 26,567 | 56,571 | |||||
Capital stock (par and additional paid-in capital) | 4,170 | 68,100 | |||||
Retained earnings | 38,738 | 37,117 | |||||
Accumulated other comprehensive income (loss) | (730 | ) | 230 | ||||
Less: Treasury stock and other equity adjustments | (7,011 | ) | (32,097 | ) | |||
Total shareholders' equity | 35,167 | 73,350 | |||||
Total liabilities and shareholders' equity | $ | 61,734 | $ | 129,921 | |||
Income Statements | |||||||
Net sales | $ | 45,607 | $ | 48,933 | |||
Cost of goods sold | 13,058 | 10,714 | |||||
Gross profit | 32,549 | 38,219 | |||||
Operating expenses | 20,617 | 29,340 | |||||
Other (income) expensenet | (490 | ) | 3,715 | ||||
Income before taxes | 12,422 | 5,164 | |||||
Tax expense | 3,727 | 1,549 | |||||
Net income | $ | 8,695 | $ | 3,615 | * | ||
Basic net income per share | $ | 2.77 | $ | 0.57 | |||
* This is before income from discontinued operations. Evaluate and compare the two companies by responding to the following questions. Note: Because two-year comparative statements are not provided, you should use year-end balances in place of average balances as appropriate. Required: 1. For both companies, compute the ratios below. 2. Evaluate and compare the two companies.
Complete this question by entering your answers in the tabs below. Required 1 Required 2 For both companies, compute the ratios below. J&J times days times days Pfizer times days times days Receivables Turnover (#.##) Average Collection Period (#) Inventory Turnover (#.##) Average Days in Inventory (#) Profit Margin (#.##)% Asset Turnover (#.### Return on Assets (#.#)% Equity Multiplier (#.##) Return on Shareholders' Equity (#.#9% times times Required 1 Required 2 >Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started